The burden of infection with HSV-1 and HSV-2 in England and Wales: Implications for the changing epidemiology of genital herpes

Sexually Transmitted Infections

Volumn 76, Issue 3, 2000, Pages 183-187

  Vyse, A J ^a   Gay, N J ^a   Slomka, M J ^a,b   Gopal, R ^a   Gibbs, T ^a   Morgan Capner, P ^c   Brown, D W ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^b Murex Biotech Ltd   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Genital herpes; Herpes simplex virus; Prevalence

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; ANTIBODY DETECTION; ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INCIDENCE; INFANT; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERUM; SEX DIFFERENCE; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; ENGLAND; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES GENITALIS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREVALENCE; SEX DISTRIBUTION; WALES;

EID: 0033946002     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.76.3.183     Document Type: Article

References (31)

1. 1 Schomogyi M, Wald A, Corey L. Herpes simplex virus-2 infection. An emerging disease? Infect Dis Clin N Am 1998;12:47-61.
2. 2 Whitley RJ, Gnann JW. The epidemiology and clinical manifestations of herpes simplex viral infections. In: Roitman B, Whitley RJ, Lopez C, eds. The human herpes-viruses. New York: Raven Press, 1993:67-105.
3. 3 Slomka MJ, Emery L, Munday PE, et al. A comparison of PCR with virus isolation and direct antigen detection for diagnosis and typing of genital herpes. J Med Virol 1998;55:177-83.
4. 4 Slomka MJ. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus. Commun Dis Rep 1996;6:R41-5.
5. 5 Ashley RL, Wald A. Genital herpes: review of the epidemic and potential uses of type specific serology. Glin Microbiol Rev 1999;12:1-8.
6. 6 Ades AE, Peckham CS, Dale GE, et al. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Commun Health 1989;43:53-60.
7. 7 Cowan FM, Johnson AM, Ashley R, et al. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ 1994;309:1325-9.
8. 8 Morgan-Capner P, Wright J, Miller CL, et al. Surveillance of antibody to measles, mumps and rubella by age. BMJ 1988;297:770-2.
9. 9 Osborne K, Gay N, Hesketh L, et al. Ten years of serological surveillance in England and Wales: methods, results, implications and action. Int J Epidemiol 2000 (in press).
10. 10 Slomka MJ, Ashley RL, Cowan FM, et al. Monoclonal antibody blocking tests for the detection of HSV-1 and HSV-2 specific humoral responses: comparison with western blot assay. J Virol Meth 1995;55:914-20.
11. 11 Gopal R, Gibbs T, Slomka MJ, et al. A monoclonal blocking EIA for herpes simplex virus type 2 (HSV-2) antibody: validation for seroepidemiological studies in Africa. J Virol Meth 2000 (in press).
12. 12 Parker RA, Erdman DD, Anderson LJ. Use of mixture models in determining laboratory criterion for identification of seropositive individuals: application to parvovirus B19 serology. J Virol Meth 1990;27:135-14.
13. 13 Robinson AJ. Sexually transmitted organisms in children and child sexual abuse. Int J STD AIDS 1998;9:501-11.
14. 14 Ashley RL, Militoni J, Nahmias AJ, et al. Comparison of western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay. J Clin Microbiol 1988;26:662-7.
15. 15 Nahmias AJ, Josey WE, Naib ZM, et al. Antibodies to herpesvirus hominis types 1 and 2 in humans. I. Patients with genital herpetic infections. Am J Epidemiol 1970;91: 539-46.
16. 16 Smith IW, Peutherer JF, MacCallum FO. The incidence of herpesvirus hominis antibody in the population. J Hyg Camb 1967;65:395-408.
17. 17 Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-11.
18. 18 Forsgren M, Skoog E, Jeansson S, et al. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS 1994;5:113-16.
19. 19 Nahmias AJ, Lee FK, Beckman-Nahmias S. Seroepidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1990;Suppl 69:19-36.
20. 20 Barton IG, Kinghorn GR, Najem S, et al. Incidence of herpes simplex virus types 1 and 2 isolated in patients with herpes genitalis in Sheffield. Br J Vener Dis 1982;58:44-7.
21. 21 Ross JDC, Smith IW, Elton RA. The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. Genitourin Med 1993;69:381-3.
22. 22 Wilson P, Cropper L, Sharp I, Fink C. Apparent increase in the prevalence of herpes simplex virus type 1 genital infections among women. Genitourin Med 1994;70:228.
23. 23 Edwards S, White C. Genital herpes simplex virus type 1 in women. Genitourin Med 1994;70:426.
24. 24 Nageswaran A, Shen RN, Kinghorn GR, et al. Apparent increase in the prevalence of herpes simplex virus type 1 genital infections among women. Genitourin Med 1994;70: 427.
25. 25 Tayal SC, Pattman RS. High prevalence of herpes simplex virus type 1 in female anogenital herpes simplex in Newcastle upon Tyne 1983-92. Int J STD AIDS 1994;5:359-61.
26. 26 Scoular A, Leask BGS, Carrington D. Changing trends in genital herpes due to herpes simplex virus type 1 in Glasgow, 1985-88. Genitourin Med 1990;66:226.
27. 27 McKenna JG, McMillan A, Blakely A, et al. Cold sores and safer sex. Lancet 1991;338:632.
28. 28 Lafferty WE, Coombs RW, Benedetti J, et al. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 1997; 316:1444-9.
29. 29 Ashley RL, Corey L. HSV type specific antibody tests: patients are ready, are clinicians? Genitourin Med 1997;73: 235-6.
30. 30 Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: WHO, 1968.
31. 31 Fricker J. Herpes vaccines: spinning a new DISC. Lancet 1996;348:1576.